(Total Views: 651)
Posted On: 03/27/2021 5:29:43 PM
Post# of 148908
Calstang,
I have been reading papers and relevant information on Long Covid, or Long Haulers (LH).
My humble conclusion: No single drug will treat LH. But my conclusion does not matter because many people are light years ahead of me in training, understanding and resources.
One of these people is Dr. Patterson. I am re-visiting this in the context of LH only (I am not referring to critical CD-16/CD-17 even-thought he could be of help here as well) . He has defined a LH score, has treated already tens of patients, run hundreds of LH blood-works and knows already more than we will know after spending some serious money and, more importantly, very valuable time. I am talking several months time-frame.
Sure, is nice to run P2 trials and learn valuable lessons from the results ... and then run P3 trials or P2b but ..
Do we have the money ??? Do we have the time ??? When we learn what needs to be done .. will there be a market for us to address ???.
Others (with much larger resources) are not waiting still for CYDY to "get our act together". This is a fast-speed cut-throat environment.
No. We need all the expertise and experience that we can get, and quick.
Patterson has it.
Even if NP has to "kiss little behind" (and pay) as somebody very ably put it.
Just pure business rationale. Nothing more, nothing less.
I am saying all this because I like Dr. Patterson?? No, because he can help us a lot immediately, we kind of know him and he knows CCR5 science very well. If not him we should be seeking somebody similar or other company involved in this quest with synergistic drug(s).
imo going solo will be misguided and arrogant. We have part of the solution only. I dare anybody to show me a study were a single drug is demonstrating the "solution" to LH.
I have been reading papers and relevant information on Long Covid, or Long Haulers (LH).
My humble conclusion: No single drug will treat LH. But my conclusion does not matter because many people are light years ahead of me in training, understanding and resources.
One of these people is Dr. Patterson. I am re-visiting this in the context of LH only (I am not referring to critical CD-16/CD-17 even-thought he could be of help here as well) . He has defined a LH score, has treated already tens of patients, run hundreds of LH blood-works and knows already more than we will know after spending some serious money and, more importantly, very valuable time. I am talking several months time-frame.
Sure, is nice to run P2 trials and learn valuable lessons from the results ... and then run P3 trials or P2b but ..
Do we have the money ??? Do we have the time ??? When we learn what needs to be done .. will there be a market for us to address ???.
Others (with much larger resources) are not waiting still for CYDY to "get our act together". This is a fast-speed cut-throat environment.
No. We need all the expertise and experience that we can get, and quick.
Patterson has it.
Even if NP has to "kiss little behind" (and pay) as somebody very ably put it.
Just pure business rationale. Nothing more, nothing less.
I am saying all this because I like Dr. Patterson?? No, because he can help us a lot immediately, we kind of know him and he knows CCR5 science very well. If not him we should be seeking somebody similar or other company involved in this quest with synergistic drug(s).
imo going solo will be misguided and arrogant. We have part of the solution only. I dare anybody to show me a study were a single drug is demonstrating the "solution" to LH.
(16)
(0)Scroll down for more posts ▼
